2026-09-07
15:20 |
|
8 p, 549.0 KB |
Socioeconomic status and equity among patients with cardiogenic shock
/
López-Sobrino, Teresa (Hospital Clínic i Provincial de Barcelona) ;
Ariza-Solé, Albert (Hospital Universitari de Bellvitge) ;
Sanz-Girgas, Esther (Institut Investigació Sanitaria Pere Virgili) ;
Aboal, Jaime (Hospital Universitari de Girona Doctor Josep Trueta) ;
Pastor, Pablo (Hospital Arnau Vilanova) ;
Buera Surribas, Irene (Hospital Universitari Vall d'Hebron) ;
Sionis, Alessandro (Institut de Recerca Sant Pau) ;
Andrea-Riba, Rut (Hospital Clínic i Provincial de Barcelona) ;
Rodríguez-López, Judit (Institut Investigació Sanitaria Pere Virgili) ;
Tomas, Carlos (Hospital Arnau Vilanova) ;
Bañeras, Jordi (Hospital Universitari Vall d'Hebron) ;
Llaó, Isaac (Hospital Universitari de Bellvitge) ;
Garcia Garcia, Cosme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Marcos-Mangas, Marta (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rueda-Sobella, Ferran (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Sánchez Salado, José Carlos (Hospital Universitari de Bellvitge) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Background: We aimed to analyze the impact of socioeconomic status (SES) on management and in-hospital outcomes of patients with cardiogenic shock (CS). Methods: This was a prospective observational registry conducted (December 2018-November 2019) in Intensive Cardiac Care Units (ICCU) across 8 tertiary care centers. [...]
2025 -  10.3389/fcvm.2025.1597225
Frontiers in Cardiovascular Medicine, Vol. 12 (2025) , art. 1597225
|
|
2026-09-04
13:12 |
|
17 p, 1.7 MB |
Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12-2022/23) : expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage
/
Mir-Cros, Alba (Hospital Universitari Vall d'Hebron) ;
Muñoz-Almagro, Carmen (Universitat Internacional de Catalunya (UIC Barcelona)) ;
Lung Suarez, Mayli del Consuelo (Hospital Universitari Vall d'Hebron) ;
Bellés-Bellés, Alba (Hospital Universitari Arnau de Vilanova) ;
Càmara, Jordi (Hospital Universitari de Bellvitge) ;
Cercenado, Emilia (Hospital General Universitario Gregorio Marañón) ;
Martín Nalda, Andrea (Hospital Universitari Vall d'Hebron) ;
Moreno Mingorance, Albert (Hospital Universitari Vall d'Hebron) ;
Navarro de la Cruz, Daniel (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Palop, Begoña (Hospital Regional Universitario de Málaga) ;
Puigsech-Boixeda, Guillem (Hospital Universitari Vall d'Hebron) ;
Quesada, Maria Dolores (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rivera, Alba (Institut de Recerca Sant Pau) ;
Rodriguez-Fernandez, Ana (Hospital Universitario Marqués de Valdecilla-IDIVAL) ;
Ruiz de Gopegui, Enrique (Institut d'Investigació Sanitària Illes Balears) ;
Viñado, Belén (Hospital Universitari Vall d'Hebron) ;
Larrosa, María Nieves (Hospital Universitari Vall d'Hebron) ;
González-López, Juanjo 1975- (Hospital Universitari Vall d'Hebron) ;
Roca, Josep (Hospital Universitari Vall d'Hebron) ;
Galán-Ladero, M. Ángeles (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Orellana, M. Ángeles (Hospital Universitario 12 de Octubre (Madrid)) ;
Pérez-Argüello, Amaresh (Hospital Sant Joan de Déu (Manresa)) ;
Sarvisé, Carolina (Hospital Universitari Joan XXIII de Tarragona) ;
Soler-Garcia, Aleix (Hospital Sant Joan de Déu (Esplugues de Llobregat, Catalunya)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Invasive meningococcal disease (IMD) is associated with significant global morbidity and mortality and is addressed by conjugated polysaccharide and subcapsular vaccines. In Spain, data on 4CMenB vaccine strain coverage and antimicrobial susceptibility are limited. [...]
2025 - 10.1080/22221751.2025.2482696
Emerging microbes & infections, Vol. 14, Num. 1 (2025) , art. 2482696
|
|
2026-07-31
11:13 |
|
14 p, 787.7 KB |
Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis : Results from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)
/
Pinter, Andreas (University Hospital of Frankfurt (Alemanya)) ;
Brnabic, Alan (Eli Lilly and Company) ;
Puig Sanz, Lluís (Institut de Recerca Sant Pau) ;
Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Megna, Matteo (University of Naples Federico II (Itàlia)) ;
Sabatino, Silvia (Eli Lilly and Company) ;
Trovato, Emanuele (Università degli Studi di Siena) ;
Boyé, Thierry (Sainte Anne Military Hospital) ;
De La Torre, Inmaculada (Eli Lilly and Company) ;
Maul, Julia-Tatjana (University of Zurich) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Introduction: The Psoriasis Study of Health Outcomes (PSoHO) is an international, prospective, non-interventional study investigating the comparative effectiveness and durability of biologic treatments for patients with moderate-to-severe psoriasis (PsO) over 36 months. [...]
2025 - 10.1007/s13555-025-01494-z
Dermatology and Therapy, Vol. 15, Num. 10 (October 2025) , p. 2819-2832
|
|
2026-07-28
14:13 |
|
18 p, 823.5 KB |
Circulating tumor DNA in patients with cancer : insights from clinical laboratory
/
Illana Cámara, Francisco José (Institut de Recerca Sant Pau) ;
Muñoz-Bravo, José Luis (Hospital General Universitario de Elche (País Valencià)) ;
González-Fernández, Carolina (Althaia Xarxa Assistencial Universitària de Manresa) ;
Trapé, Jaume (Althaia Xarxa Assistencial Universitària de Manresa) ;
Diaz-Lagares, Angel (Instituto de Salud Carlos III) ;
Fernández-Galán, Esther (Hospital Clínic i Provincial de Barcelona) ;
Valiña Amado, Laura (Institut d'Investigació Sanitària de les Illes Balears (IdISBa)) ;
Garcia-Martín, Carme (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Miró-Cañís, Sílvia (CLILAB Diagnòstics) ;
Martínez-Peinado, Antonio (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Filella, Xavier (Hospital Clínic i Provincial de Barcelona) ;
González, Alvaro (Clínica Universidad de Navarra (Madrid)) ;
Barco Sánchez, Antonio (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Blood-based circulating tumor DNA (ctDNA) analysis has emerged as a highly relevant non-invasive method for molecular profiling of solid tumors, offering valuable information about the genetic landscape of cancer. [...]
2025 - 10.1515/almed-2025-0010
Advances in Laboratory Medicine, Vol. 6, Num. 3 (January 2025) , p. 259-276
|
|
2026-07-28
11:13 |
|
10 p, 937.7 KB |
N-terminal pro B-type natriuretic peptide as biomarker to predict pre-eclampsia and maternal-fetal complications
/
Nan, Madalina Nicoleta (Institut de Recerca Sant Pau) ;
Universitat Autònoma de Barcelona.
Departament de Medicina ;
Garrido-Giménez, Carmen (Institut de Recerca Sant Pau) ;
Mora Brugués, Josefina (Institut de Recerca Sant Pau) ;
Platero, Judit (Institut de Recerca Sant Pau) ;
Cruz-Lemini, Monica (Institut de Recerca Sant Pau) ;
Llurba, Elisa (Institut de Recerca Sant Pau) ;
García Osuna, Álvaro (Institut de Recerca Sant Pau) ;
García Manau, Pablo (Instituto de Salud Carlos III) ;
Ullmo, Johana (Institut de Recerca Sant Pau) ;
Sánchez García, Olga (Institut de Recerca Sant Pau) ;
Vila-Cortés, M. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Pelegay, M. J. (Hospital Universitari Arnau de Vilanova) ;
Ricart, M (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Muñoz-Abellana, B. (Hospital Universitari Sant Joan de Reus (Tarragona)) ;
Barrios, X. Gabaldó (Hospital Universitari Sant Joan de Reus (Tarragona, Catalunya))
Objective: A soluble fms-like tyrosine kinase-1 (sFlt-1)-to-placental growth factor (PlGF) ratio cut-off of 38 is currently considered optimal for ruling out pre-eclampsia (PE); however, implementation of this ratio in clinical practice is limited. [...]
2025 - 10.1002/uog.29202
Ultrasound in obstetrics & gynecology, Vol. 65, Num. 4 (April 2025) , p. 447-455
|
|
2026-07-09
18:12 |
|
9 p, 1.1 MB |
Rapid and portable molecular test for Mycobacterium sp. based on double-tagging amplification and electrochemical readout
/
Mesas Gómez, Melania (Universitat Autònoma de Barcelona. Departament de Química) ;
Ropero Gil, Daniel (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ;
Molina-Moya, Barbara (Institut Germans Trias i Pujol) ;
Pallarès-Rusiñol, Arnau (BioEclosion SL) ;
Ferrer-Dalmau, Jofre (BioEclosion SL) ;
Julián, Esther (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Domínguez, José (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ;
Pividori, María Isabel (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
Tuberculosis (TB) remains one of the leading causes of death worldwide, with Mycobacterium tuberculosis as the main pathogen responsible. Although several rapid molecular tests endorsed by the World Health Organization (WHO) show high accuracy, their implementation in low-resource settings is still limited by cost and infrastructure requirements. [...]
2026 - 10.1039/d6sd00037a
Sensors & diagnostics, April 2026
|
|
2026-06-29
10:15 |
|
13 p, 253.3 KB |
Characterisation of new HIV diagnoses achieved in emergency departments using an opt-in strategy, Catalonia, Spain, July 2021 to March 2024
/
Llaneras Artigues, Jordi (Hospital Universitari Vall d'Hebron) ;
Álvarez-López, Patricia (Hospital Universitari Vall d'Hebron) ;
de Paz, Rocío (Hospital del Mar (Barcelona, Catalunya)) ;
Carbó, Míriam (Hospital Clínic i Provincial de Barcelona) ;
Saura, Mireia (Hospital Arnau de Vilanova) ;
Rebollo, Alexis (Hospital Universitari de Bellvitge) ;
Robert, Neus (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Guardiola Tey, Jose Maria (Institut de Recerca Sant Pau) ;
Leey, Connie (Althaia Xarxa Assistencial Universitària de Manresa) ;
González-García, Laura (Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IRIS-CC)) ;
Rando-Segura, Ariadna (Hospital Universitari Vall d'Hebron) ;
Curran, Adrian (Hospital Universitari Vall d'Hebron) ;
Gené Tous, Emilio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Miró, Oscar (Hospital Clínic i Provincial de Barcelona) ;
Olaizola, Cristina (Hospital de Mataró) ;
Carrillo, Alberto (Hospital Sant Pau i Santa Tecla (Tarragona)) ;
Ramió Lluch, Cristina (Hospital Universitari de Girona Doctor Josep Trueta) ;
Smithson, Alex (Hospital Esperit Sant. Santa Coloma de Gramanet) ;
Rodríguez-Masià, Ferran (Hospital de Tortosa Verge de la Cinta) ;
Ferro Alem, José Ignacio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Michelini, Mariola (Hospital de Viladecans) ;
Sotomayor, Margarita (Hospital de Sant Joan Despí Moisès Broggi) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Background: HIV screening strategies in alternative settings, such as emergency departments (EDs), aim to increase diagnosis of occult infections and achieve 95-95-95 targets for 2030. Aim: To assess the effectiveness of an opt-in HIV screening strategy in EDs based on six clinical scenarios from a 2020 Spanish consensus document, while examining patient characteristics and linkage to-care. [...]
2025 - 10.2807/1560-7917.ES.2025.30.47.2400781
Eurosurveillance, Vol. 30, Num. 47 (November 2025) , art. 2400781
|
|
2026-07-13
12:12 |
|
14 p, 1.6 MB |
Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis : a multicenter cross-sectional study in Catalonia, Spain
/
Sola, Nuria Rudi (Hospital General de Granollers) ;
De Pourcq, Jan T. (Institut de Recerca Sant Pau) ;
Quiñones Ribas, Carles (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Borràs Trias, Laura (Hospital General de Granollers) ;
Figueiredo-Escribá, Carlos (Universitat de Barcelona) ;
Delgado-Hernández, René (Universitat de Barcelona) ;
Braza, Antonio J. (Universitat de Barcelona) ;
Lastra, Cecilia F. (Universitat de Barcelona) ;
Mariño, Eduardo L. (Universitat de Barcelona) ;
Modamio, Pilar (Universitat de Barcelona) ;
Mas Marin, Joan (Universitat de Barcelona) ;
Molina-Olano, Marina (Universitat de Barcelona) ;
Miserachs-Aranda, Núria (Fundació Hospital de l'Esperit Sant) ;
Montoliu Alcón, Paula (Hospital del Sagrat Cor (Barcelona, Catalunya)) ;
Fernández-Cañabate, Eva (Fundació Hospital de l'Esperit Sant) ;
González-Valdivieso, Juan (Hospital del Sagrat Cor (Barcelona, Catalunya)) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Objective: The objective of this study is to compare the effectiveness of reference biologic medicines used in the treatment of rheumatoid arthritis (RA) specifically adalimumab, etanercept, and infliximab, with corresponding biosimilar medicines, based on an exploratory analysis of clinical data obtained in patients treated with these medicines in five hospitals in the region of Catalonia, Spain. [...]
2025 - 10.1007/s10067-025-07568-9
Clinical Rheumatology, Vol. 44, Num. 9 (September 2025) , p. 3445-3458
|
|
2026-06-18
14:12 |
|
10 p, 2.2 MB |
Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results
/
Borque-Fernando, Ángel (Hospital Universitario Miguel Servet (Saragossa)) ;
Sanguedolce, Francesco (Institut de Recerca Sant Pau) ;
Giménez Bachs, J. M. (Hospital Universitario Albacete) ;
Herrera Imbroda, B. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ;
Reyes, A. (Hospital Calatayud. Ernest Lluch) ;
Rubio-Briones, J. (Hospital VITHAS 9 de Octubre) ;
Esteban Escaño, L. M. (Hospital Escuela Universitaria La Almunia) ;
Wong, A. (Hospital Instituto Valenciano de Oncología) ;
Guijarro Cascales, A. (Hospital Fundación Alcorcón) ;
Gómez Gómez, E. (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Gil Fabra, J. M. (Hospital Universitario Miguel Servet (Saragossa)) ;
Gomez Veiga, F. (Hospital Universitario de Salamanca) ;
López González, P. A. (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ;
Plata Bello, A. (Hospital Universitario de Canarias (La Laguna)) ;
Rodríguez García, N. (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Montesino Semper, M. (Hospital Virgen del Camino (Pamplona)) ;
Suárez-Novo, José Francisco (Hospital Universitari de Bellvitge) ;
Hajianfar, R. (Hospital de Sant Joan Despí Moisès Broggi) ;
Fumadó, Lluís (Hospital del Mar (Barcelona, Catalunya)) ;
González Alfaro, A. (Hospital Móstoles) ;
Duarte Ojeda, J. M. (Hospital Universitario 12 de Octubre (Madrid)) ;
Bono Ariño, A. (Hospital San Jorge (Osca,Aragó)) ;
Quicios Dorado, C. (Hospital Universitario Fundación Jiménez Díaz) ;
Loizaga Iriarte, A. (Hospital Basurto) ;
García Fadrique, G. (Hospital Manises) ;
García-Barreras, Silvia (Hospital Universitario Ramón y Cajal (Madrid)) ;
Pallas Costa, Y. (Consorcio Hospital General Universitario (València)) ;
Vilaseca Cabo, Antoni (Hospital Clínic i Provincial de Barcelona) ;
Rodrigo Aliaga, M. (Consorcio Hospital General Universitario (València)) ;
Campanario Pérez, F. (Hospital Complejo Asistencial Universitario) ;
Servian, Pol (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Campá Bortoló, J. M. (Arabako Unibertsitate Ospitalea (Vitoria, País Basc)) ;
Soto Delgado, M. (Hospital Universitario Puerta del Mar (Cadis, Andalusia)) ;
Rodríguez de Ledesma, J. M. (Hospital CST Terrasa) ;
Sanchez Rodriguez, C. (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Chantada Abal, V. (Hospital CHUAC) ;
Hernández Martínez, Y. E. (Hospital Manacor) ;
Dolezal, P. (Hospital Barbastro) ;
Gual Frau, J. (Hospital Xátiva) ;
Medrano Llorente, P. (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Moreno Jiménez, J. (Complejo Hospitalario de Jaén) ;
Serrano Uribe, J. S. (Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid)) ;
Congregado Ruiz, C. B. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Fernández Aparicio, T. (Hospital General Universitario Morales Meseguer (Múrcia)) ;
García Rodríguez, J. (Hospital Universitario Central) ;
Cuadras Solé, Mercè (Hospital Universitari Vall d'Hebron) ;
García Seguí, A. (Hospital General Universitario de Elche) ;
Pacheco Bru, J. J. (Hospital Universitari Sant Joan d'Alacant) ;
Mayor de Castro, J. (Hospital General Universitario Gregorio Marañón) ;
Mira Moreno, A. (Hospital General de Elda) ;
Molina Suárez, J. L. (Hospital Vírgen del Puerto) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Patients and Methods: In this multicenter longitudinal study, data from the Spanish Register in AS (AEU-PIEM/2014/0001) were reviewed. The study focused on a cohort of AS patients registered between 2014 and 2019, featuring open inclusion criteria and diverse follow-up strategies. [...]
2025 - 10.1002/cam4.71173
Cancer Medicine, Vol. 14, Num. 17 (September 2025) , art. e71173
|
|
2026-06-05
11:12 |
|
11 p, 2.1 MB |
Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials
/
Yosipovitch, Gil (University of Miami Miller School of Medicine) ;
Lio, Peter (Medical Dermatology Associates of Chicago) ;
Rosmarin, David (Indiana University School of Medicine) ;
Serra Baldrich, Esther (Institut de Recerca Sant Pau) ;
Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Crane, Heidi (Eli Lilly and Company) ;
Casillas, Marta (Eli Lilly and Company) ;
Pierce, Evangeline (Eli Lilly and Company) ;
Elmaraghy, Hany (Eli Lilly and Company) ;
Ständer, Sonja (University Hospital of Münster (Alemanya)) ;
Legat, Franz Josef (Medical University of Graz (Àustria)) ;
Bardolet, Laia (Almirall (Barcelona)) ;
Zhong, Jinglin (IQVIA) ;
Universitat Autònoma de Barcelona.
Departament de Medicina
Introduction: Lebrikizumab significantly reduced itch and itch interference on sleep in patients with moderate-to-severe atopic dermatitis (AD) at week 16 in two phase 3 trials. We investigated itch reduction and the efficacy of improving itch interference on sleep in lebrikizumab-treated patients over 52 weeks. [...]
2025 - 10.1159/000547142
Dermatology, Vol. 241, Num. 4 (October 2025) , p. 325-335
|
|
|
|
|
visitant ::
identificació
Estadístiques d'ús
Els més consultats
